Episoder
-
Dr. Lalani and Dr. Wallis cover the utility of metformin, quality of life analyses, and optimizing treatment approaches for resistant prostate cancer, including the place for radioligand therapies.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers.
Learn more about The View on GU: https://theviewongu.com
This podcast has been made possible through financial support by Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, Merck, Novartis, Pfizer and TerSera.
-
Our hosts start by discussing the 901 trial before moving into a discussion about bladder preservation and the importance of being multi-disciplinary.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers.
Learn more about The View on GU: https://theviewongu.com
This podcast has been made possible through financial support by Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, Merck, Novartis, Pfizer and TerSera.
-
Manglende episoder?
-
The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers.
Learn more about The View on GU: https://theviewongu.com
This podcast has been made possible through financial support by Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, Merck, Novartis, Pfizer and TerSera.
-
Joined by MD Anderson Cancer Center clinician and scientist Dr. Pavlos Msaouel, Dr. Aly-Khan Lalani and Dr. Christopher Wallis discuss trial design and statistics in oncology. What are the nuances to reading KM curves? How useful are forest plots? Our guest and hosts dive into this and more in Episode 8.
The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers.
Learn more about The View on GU: https://theviewongu.com
This podcast has been made possible through financial support by AstraZeneca, Bristol Myers Squibb, Merck, and TerSera.
-
Episode 7 was filmed live in Niagara, Ontario at the 13th Annual Juravinski Cancer Centre and Walker Cancer Centre Uro-oncology Forum! Our hosts discuss Dr. Christopher Wallis’ presentation about physician and surgeon gender and how it impacts patient care, surgical outcomes, mortality and more - especially in the field of genitourinary cancers. The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: https://theviewongu.com
This podcast has been made possible through financial support by AstraZeneca, Bristol Myers Squibb, Merck, and TerSera.
-
In Episode 6, Drs. Aly-Khan Lalani and Christopher Wallis are joined by The View on GU’s first guest Dr. Diana Magee to discuss why location matters when it comes to medical conferences. They touch upon Dr. Magee’s recent article in The Journal of Urology, and consider the ethical, economic and political implications of the upcoming American Urological Association conference in Texas following implementation of the state’s abortion ban. The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: https://theviewongu.com
This podcast has been made possible through financial support by Bristol Myers Squibb, Merck, and TerSera.
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of hospital corporations and are not intended to be personal medical advice.
-
In Episode 5, Drs. Aly-Khan Lalani and Christopher Wallis discuss biochemical recurrence in prostate cancer, including what they’re seeing in the field right now in terms of treatment options, what physicians should know moving forward and multi-D care for patients. The doctors also provide an overview of the recent EMBARK trial, noting efficacy outcomes and key learnings. The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: https://theviewongu.com
This podcast has been made possible through financial support by Bristol Myers Squibb, Merck, and TerSera.
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of hospital corporations and are not intended to be personal medical advice.
-
After returning from the 2024 ASCO Genitourinary Cancers Symposium in San Francisco, our hosts Drs. Aly-Khan Lalani and Christopher Wallis share key takeaways for clinical practice and their thoughts on high impact presentations about prostate, kidney, and bladder cancers, expanding on their discussions from Episodes 1-3. The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: https://theviewongu.com/
This podcast has been made possible through financial support by Bristol Myers Squibb, Merck, and TerSera.
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of hospital corporations and are not intended to be personal medical advice.
-
Filmed live at #GU24, episode 3 of The View on GU features a discussion on survival data with adjuvant therapy for patients with resected kidney cancer, as well as long-term followup for those with metastatic disease.
The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications into meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers. Filmed live at the 2024 ASCO Genitourinary Cancers Symposium, Drs. Aly-Khan Lalani and Christopher Wallis discuss survival outcomes for adjuvant therapy, and exciting updated datasets in episode 3. Learn more about The View on GU: theviewongu.com
This podcast has been made possible through financial support by Bristol Myers Squibb, Merck, and TerSera.
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of hospital corporations and are not intended to be personal medical advice.
-
Filmed live at #GU24, episode 2 of The View on GU examines late breaking data for patients with urothelial carcinoma.
The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications into meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers. Filmed live at the 2024 ASCO Genitourinary Cancers Symposium, Drs. Aly-Khan Lalani and Christopher Wallis examine new and updated data, and recent achievements in urothelial carcinoma research. Learn more about The View on GU: theviewongu.com
This podcast has been made possible through financial support by Bristol Myers Squibb, Merck, and TerSera.
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of hospital corporations and are not intended to be personal medical advice.
-
Filmed live at #GU24, episode 1 of The View on GU dives into new and updated data and novel treatment approaches for patients with prostate cancer.
The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications into meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers. Filmed live at the 2024 ASCO Genitourinary Cancers Symposium in San Francisco, Drs. Aly-Khan Lalani and Christopher Wallis discuss new and updated data and integrate what these trials mean for practicing clinicians. Learn more about The View on GU: theviewongu.com
This podcast has been made possible through financial support by Bristol Myers Squibb, Merck, and TerSera.
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of hospital corporations and are not intended to be personal medical advice.
-
A new podcast developed by clinicians for clinicians, focused on optimizing multi-disciplinary healthcare within the field of genitourinary cancers.
This podcast has been made possible through financial support by Bristol Myers Squibb, Merck, and TerSera.
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of hospital corporations and are not intended to be personal medical advice.
